Neuralynx (An FHC Company)

Neuralynx, an FHC Company, specializes in electrophysiology data recording systems and solutions for neuroscience research and human medical data recording. Founded in 1993, the company has developed advanced technologies for detecting and classifying neural signals, including single electrode and stereo-trode spike waveforms. Their product lineup features the Digital Lynx series, which supports high-density, multichannel neural recording with up to 1024 channels, and the wireless Digital Falcon system. They also offer the FDA-cleared ATLAS Neurophysiology System, designed for identifying and analyzing epileptic signals in human research. In 2021, Neuralynx merged with FHC, Inc., enhancing their capabilities in neuroscience research and clinical applications. The company is committed to providing comprehensive customer support, including system setup, custom device integration, and extensive documentation. Their primary customers include neuroscience researchers, electrophysiologists, functional neurosurgeons, and neurologists, with systems utilized in both animal and human research settings. Neuralynx aims to advance neuroscience by delivering reliable electrophysiology hardware and software solutions.

• Employees 26
• Founded 1993
• Annual Revenue $51106000